Prothena Corporation Announces New Compensation Agreements for Key Executives, Including Enhanced Severance Benefits

Reuters

2025/07/31

Prothena Corporation Announces New Compensation Agreements for Key Executives, Including Enhanced Severance Benefits

Prothena Corporation plc has announced new employment agreements for key executives at its subsidiary, Prothena Biosciences Inc. Effective July 30, 2025, Tran B. Nguyen, Chief Strategy Officer and CFO; Brandon S. Smith, COO; and Wagner M. Zago, Ph.D., Chief Scientific Officer, will receive annual base salaries of $603,792, $544,201, and $518,000 respectively. Each will be eligible for a discretionary annual cash bonus, with target percentages set at 50% for Nguyen and Smith, and 40% for Zago. In cases of termination without cause or resignation with good reason, the executives will receive severance benefits including 100% of their base salary and target bonus, plus up to 12 months of health coverage. These benefits increase to 150% of base salary and target bonus, and up to 18 months of health coverage, if termination occurs in connection with a change in control. The agreements also include provisions for accelerated vesting of equity awards.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Prothena Corporation plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-169367), on July 30, 2025, and is solely responsible for the information contained therein.

應版權方要求，你需要登入查看該內容

登入 / 註冊

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"澳洲华人首选美澳港股一站式交易平台 | 老虎证券","description":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","keywords":"老虎证券,老虎证券澳洲,老虎证券股票,老虎证券开户,老虎证券app,tigertrade老虎证券,股票,asx美股,炒股,券商,澳洲股票交易,澳大利亚炒股","social":{"ogDescription":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2555655027"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2555655027\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2555655027?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-07-31 05:16","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2555655027","market":"nz","top_or_hot":-1,"title":"Prothena Corporation Announces New Compensation Agreements for Key Executives, Including Enhanced Severance Benefits","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Prothena Corporation Announces New Compensation Agreements for Key Executives, Including Enhanced Severance Benefits\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        <a href=\"https://laohu8.com/S/PRTA\">Prothena Corporation plc</a> has announced new employment agreements for key executives at its subsidiary, Prothena Biosciences Inc. Effective July 30, 2025, Tran B. Nguyen, Chief <a href=\"https://laohu8.com/S/MSTR\">Strategy</a> Officer and CFO; Brandon S. Smith, COO; and Wagner M. Zago, Ph.D., Chief Scientific Officer, will receive annual base salaries of $603,792, $544,201, and $518,000 respectively. Each will be eligible for a discretionary annual cash bonus, with target percentages set at 50% for Nguyen and Smith, and 40% for Zago. In cases of termination without cause or resignation with good reason, the executives will receive severance benefits including 100% of their base salary and target bonus, plus up to 12 months of health coverage. These benefits increase to 150% of base salary and target bonus, and up to 18 months of health coverage, if termination occurs in connection with a change in control. The agreements also include provisions for accelerated vesting of equity awards.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Prothena Corporation plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-169367), on July 30, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Prothena Corporation Announces New Compensation Agreements for Key Executives, Including Enhanced Severance Benefits</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nProthena Corporation Announces New Compensation Agreements for Key Executives, Including Enhanced Severance Benefits\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time smaller\">2025-07-31 05:16</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Prothena Corporation Announces New Compensation Agreements for Key Executives, Including Enhanced Severance Benefits\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        <a href=\"https://laohu8.com/S/PRTA\">Prothena Corporation plc</a> has announced new employment agreements for key executives at its subsidiary, Prothena Biosciences Inc. Effective July 30, 2025, Tran B. Nguyen, Chief <a href=\"https://laohu8.com/S/MSTR\">Strategy</a> Officer and CFO; Brandon S. Smith, COO; and Wagner M. Zago, Ph.D., Chief Scientific Officer, will receive annual base salaries of $603,792, $544,201, and $518,000 respectively. Each will be eligible for a discretionary annual cash bonus, with target percentages set at 50% for Nguyen and Smith, and 40% for Zago. In cases of termination without cause or resignation with good reason, the executives will receive severance benefits including 100% of their base salary and target bonus, plus up to 12 months of health coverage. These benefits increase to 150% of base salary and target bonus, and up to 18 months of health coverage, if termination occurs in connection with a change in control. The agreements also include provisions for accelerated vesting of equity awards.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Prothena Corporation plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-169367), on July 30, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250730:nNDL74ljgZ:1","article_id":"2555655027","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2555655027","pubTimestamp":1753910165,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Prothena Corporation plc has announced new employment agreements for key executives at its subsidiary, Prothena Biosciences Inc. Effective July 30, 2025, Tran B. Nguyen, Chief Strategy Officer and CFO; Brandon S. Smith, COO; and Wagner M. Zago, Ph.D., Chief Scientific Officer, will receive annual base salaries of $603,792, $544,201, and $518,000 respectively. Each will be eligible for a discretionary annual cash bonus, with target percentages set at 50% for Nguyen and Smith, and 40% for Zago. In cases of termination without cause or resignation with good reason, the executives will receive severance benefits including 100% of their base salary and target bonus, plus up to 12 months of health coverage. These benefits increase to 150% of base salary and target bonus, and up to 18 months of health coverage, if termination occurs in connection with a change in control. The agreements also include provisions for accelerated vesting of equity awards.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","PRTA":"Prothena Corporation plc"},"translate_title":"Prothena Corporation宣布针对关键高管的新薪酬协议，包括提高遣散费","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PRTA":0.9},"content_text":"Prothena Corporation Announces New Compensation Agreements for Key Executives, Including Enhanced Severance Benefits\n    \n\nProthena Corporation plc has announced new employment agreements for key executives at its subsidiary, Prothena Biosciences Inc. Effective July 30, 2025, Tran B. Nguyen, Chief Strategy Officer and CFO; Brandon S. Smith, COO; and Wagner M. Zago, Ph.D., Chief Scientific Officer, will receive annual base salaries of $603,792, $544,201, and $518,000 respectively. Each will be eligible for a discretionary annual cash bonus, with target percentages set at 50% for Nguyen and Smith, and 40% for Zago. In cases of termination without cause or resignation with good reason, the executives will receive severance benefits including 100% of their base salary and target bonus, plus up to 12 months of health coverage. These benefits increase to 150% of base salary and target bonus, and up to 18 months of health coverage, if termination occurs in connection with a change in control. The agreements also include provisions for accelerated vesting of equity awards.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Prothena Corporation plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-169367), on July 30, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"executive","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}